Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 May 31;102(22):7910-5.
doi: 10.1073/pnas.0502206102. Epub 2005 May 23.

Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments

Peter J McCormick  1 , José A Martina, Juan S Bonifacino
Affiliations
Comparative Study

Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments

Peter J McCormick et al. Proc Natl Acad Sci U S A. .

Abstract

Major histocompatibility complex class II (MHC-II) molecules are composed of two polymorphic chains, alpha and beta, which assemble with an invariant chain, Ii, in the endoplasmic reticulum. The assembled MHC-II complexes are transported to the Golgi complex and then to late endosomes/lysosomes, where Ii is degraded and alphabeta dimers bind peptides derived from exogenous antigens. Targeting of MHC-II molecules to these compartments is mediated by two dileucine-based signals in the cytoplasmic domain of Ii. These signals bind in vitro to two adaptor protein (AP) complexes, AP-1 and AP-2, which are components of clathrin coats involved in vesicle formation and cargo sorting. The physiological roles of these proteins in MHC-II molecule trafficking, however, remain to be addressed. Here, we report the use of RNA interference to examine the involvement of clathrin and four AP complexes (AP-1, AP-2, AP-3, and AP-4) in MHC-II molecule trafficking in vivo. We found that depletion of clathrin or AP-2 caused >10-fold increases in Ii expression on the cell surface and a concomitant decrease in Ii localization to endosomal/lysosomal vesicles. In addition, depletion of clathrin or AP-2 delayed the degradation of Ii and reduced the surface expression of peptide-loaded alphabeta dimers. In contrast, depletion of AP-1, AP-3, or AP-4 had little or no effect. These findings demonstrate that clathrin and AP-2 participate in MHC-II molecule trafficking in vivo. Because AP-2 is only associated with the plasma membrane, these results also indicate that a significant pool of MHC-II molecules traffic to the endosomal-lysosomal system by means of the cell surface.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Efficient knockdown of CHC and AP-μ subunits in Mel JuSo and HeLa-CIITA cells. (A) HeLa-CIITA and Mel JuSo cells were mock-treated or treated with siRNA oligonucleotides for μ1A, μ2, μ3A, and CHC. Immunoblot (IB) analysis was performed by using antibodies to the proteins indicated. (B) Immunofluorescence (IF) microscopy of mock-treated and μ4-siRNA-treated HeLa-CIITA and Mel JuSo cells with rabbit antibody to β4. (C) FACS analysis of TfR and MHC-I surface expression in HeLa-CIITA cells that were either mock-treated (open curves) or treated with siRNAs directed to the indicated proteins (shaded curves). Primary antibodies to TfR (DF 1513) and MHC-I (W6/32) were used, followed by incubation with phycoerythrin-conjugated anti-mouse IgG.
Fig. 2.
Fig. 2.
FACS analysis of Ii and MHC II in HeLa-CIITA cells depleted of CHC and AP-μ subunits. (A) FACS analysis of Ii surface expression in HeLa-CIITA cells that were either mock-treated (open curves) or treated with siRNAs to the indicated proteins (shaded curves). Staining was with primary antibody to Ii (M-B741), followed by phycoerythrin-conjugated anti-mouse IgG. (B) Results (mean ± SD) from five separate experiments were quantified and graphed as a fold increase relative to the mock experiment. (C and D) HeLa-CIITA cells were either mock-treated (open curves) or treated with siRNAs to μ2orCHC (shaded curves). Cells were stained with either the TDR31.1 antibody (to measure total MHC-II molecule surface expression) (C) or the L243 antibody (to measure peptide-loaded MHC-II molecules) (D) and analyzed by FACS.
Fig. 3.
Fig. 3.
Immunofluorescence microscopy of nonpermeabilized (A–I) and permeabilized (J–L) Mel JuSo cells that were either mock-treated or treated with siRNAs to μ2 or CHC. Cells were stained with antibodies to Ii (M-B741 or Pin-1), total MHC-II (TDR31.1), and peptide-loaded MHC-II (L243).
Fig. 4.
Fig. 4.
Effects of CHC and μ2 depletion on Ii degradation and surface expression of Ii-associated α and β chains. (A) Mock-, CHC-, or μ2-depleted Mel JuSo cells were pulse-labeled with [35S]methionine-cysteine for 20 min and chased for the times indicated. Immunoprecipitations were then performed by using the Pin-1 antibody to Ii and analyzed by SDS/PAGE. (B) Mock-, CHC-, or μ2-depleted Mel JuSo cells were incubated, pulse-labeled, and chased for the indicated times in the presence of 1 mM leupeptin. Pin-1 immunoprecipitations were again performed, and the samples were resolved by SDS/PAGE. The p8–10 Ii degradation intermediates are indicated. The positions of molecular mass markers (in kDa) are indicated. (C) The results from A and B were quantified by using imagequant software (Molecular Dynamics) as a percentage of protein at time = 0. (D) HeLa-CIITA cells were either mock-treated or treated with siRNAs to μ2 or CHC as before. The cells were then surface-biotinylated, lysed, and immunoprecipitated with the Pin-1 antibody to Ii. The redissolved immunoprecipitates were then reimmunoprecipitated with the DA6.147 antibody to MHC-II. Next, the samples were analyzed by SDS/PAGE, and biotinylated proteins were detected by using strepdavidin coupled to horseradish peroxidase. The positions of molecular mass markers and the α and β chains are indicated.
Fig. 5.
Fig. 5.
HeLa-CIITA cells were either mock-treated or treated with siRNAs directed to CHC or μ2. (A) Cathepsin D activity was measured biochemically in cell lysates by using a fluorogenic substrate specific for this enzyme. Values represent the mean enzymatic activity (in arbitrary units) ± SD from three separate experiments done in triplicate. (B–D) Cathepsin K activity was visualized by fluorescence microscopy of live cells incubated with a specific fluorogenic substrate. The cells were also labeled with DAPI to stain the nuclei.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Holling, T. M., Schooten, E. & Van Den Elsen, P. J. (2004) Hum. Immunol. 65, 282–290. - PubMed
    1. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L. & Geuze, H. J. (1991) Nature 349, 669–676. - PubMed
    1. Amigorena, S., Webster, P., Drake, J., Newcomb, J., Cresswell, P. & Mellman, I. (1995) J. Exp. Med. 181, 1729–1741. - PMC - PubMed
    1. Castellino, F. & Germain, R. N. (1995) Immunity 2, 73–88. - PubMed
    1. Cresswell, P. (1994) Annu. Rev. Immunol. 12, 259–293. - PubMed

Publication types

MeSH terms